Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migalastat Phase 2 in Female Fabry Disease
NCT00304512Phase 2Completed
- Sponsor
- Amicus Therapeutics
- Start
- Sep 2006
- Primary completion
- May 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of migalastat in Fabry disease (FD), sponsored by Amicus Therapeutics. Started Sep 2006; status: completed.
02
Drugs
migalastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00304512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304512.